VEGFR2 Antibody / KDR Polyclonal Antibody (R32871)

VEGFR2 Antibody in Human Intestinal Cancer IHC. Immunohistochemistry staining of FFPE human intestinal cancer tissue with VEGFR2 Antibody at 1 ug/ml. HIER was performed by steaming sections in pH 6 citrate buffer for 20 min followed by cooling before testing. Brown immunoreactivity is distributed through tumor-associated cellular and vascular structures, with nuclei counterstained blue. The staining pattern demonstrates detection of KDR protein in malignant intestinal tissue with the KDR Polyclonal Antibody.

VEGFR2 Antibody in Human Lung Cancer IHC. Immunohistochemistry staining of FFPE human lung cancer tissue with VEGFR2 Antibody at 1 ug/ml. HIER was performed by steaming sections in pH 6 citrate buffer for 20 min followed by cooling before testing. Strong brown immunoreactivity is particularly prominent along an elongated vascular structure, with additional staining present in surrounding tumor tissue. This vascular-associated pattern supports detection of VEGFR2 in human lung cancer with the KDR Polyclonal Antibody.

VEGFR2 Antibody in Human Breast Cancer IHC. Immunohistochemistry staining of FFPE human breast cancer tissue with VEGFR2 Antibody at 1 ug/ml. HIER was performed by steaming sections in pH 6 citrate buffer for 20 min followed by cooling before testing. Brown immunoreactivity is visible in clusters of malignant epithelial cells within the surrounding stromal tissue, with variation in staining intensity across the field. The cellular staining demonstrates detection of KDR with the KDR Polyclonal Antibody.

VEGFR2 Antibody in Human Placenta IHC. Immunohistochemistry staining of FFPE human placenta tissue with VEGFR2 Antibody at 1 ug/ml. HIER was performed by steaming sections in pH 6 citrate buffer for 20 min followed by cooling before testing. Distinct brown staining outlines multiple vascular structures, with particularly strong labeling of vessel-associated cells against comparatively weak surrounding tissue. This vascular staining pattern provides biologically relevant tissue validation for the KDR Polyclonal Antibody.

VEGFR2 Antibody in MCF7 Cells WB. Western blot testing of human MCF7 cell lysate with VEGFR2 Antibody at 0.5 ug/ml. The blot shows prominent immunoreactive bands at approximately 180 kDa and 100 kDa. VEGFR2 is expected to occur in differently processed and glycosylated forms, with the product page listing approximately 152 kDa for immature receptor, 180-200 kDa for intermediate forms and 220-230 kDa for mature receptor. The upper band is therefore compatible with a processed VEGFR2 species, while the lower band may represent an additional receptor form or nonspecific reactivity. This experiment provides western blot validation for the KDR Polyclonal Antibody.